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OBJECTIVES: Patients with coronary artery disease and left ventricular dysfunction have high mortality when kept in
clinical treatment. Coronary artery bypass grafting can improve survival and the quality of life. Recently,
revascularization without cardiopulmonary bypass has been presented as a viable alternative. The aim of this study
is to compare patients with left ventricular ejection fractions of less than 20% who underwent coronary artery
bypass graft with or without cardiopulmonary bypass.
METHODS: From January 2001 to December 2005, 217 nonrandomized, consecutive, and nonselected patients with
an ejection fraction less than or equal to 20% underwent coronary artery bypass graft surgery with (112) or without
(off-pump) (105) the use of cardiopulmonary bypass. We studied demographic, operative, and postoperative data.
RESULTS: There were no demographic differences between groups. The outcome variables showed similar graft
numbers in both groups. Mortality was 12.5% in the cardiopulmonary bypass group and 3.8% in the off-pump
group. Postoperative complications were statistically different (cardiopulmonary bypass versus off-pump): total
length of hospital stay (days)—11.3 vs. 7.2, length of ICU stay (days)—3.7 vs. 2.1, pulmonary complications—10.7%
vs. 2.8%, intubation time (hours)—22 vs. 10, postoperative bleeding (mL)—654 vs. 440, acute renal failure—8.9% vs.
1.9% and left-ventricle ejection fraction before discharge—22% vs. 29%.
CONCLUSION: Coronary artery bypass grafting without cardiopulmonary bypass in selected patients with severe left
ventricular dysfunction is valid and safe and promotes less mortality and morbidity compared with conventional
operations.
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INTRODUCTION
Despite several advances in the treatment of coronary artery
disease, many patients, especially those with multivessel
disease and complex anatomies, benefit greatly when subjected
to surgical treatment. In the presence of ventricular dysfunc-
tion, the difference between medical treatment or angioplasty
compared with surgical intervention is even more impressive.1
Coronary artery bypass grafting (CABG) with cardiopul-
monary bypass (CPB) and cardioplegic arrest is considered
the gold standard in intervention with well-documented
and consistent outcomes. Nevertheless, it is known that the
use of cardiopulmonary bypass has major drawbacks, such
as the inflammatory reaction and the potential induction of
multiple-organ dysfunction.2-5
However, there are a number of advantages of using the
technique of myocardial revascularization without cardio-
pulmonary bypass (off-pump); myocardial ischemia is
regional rather than global and the technique is performed
only in the area of the coronary artery that is being grafted,
which possibly reduces injury to the myocardium and
contributes to better results.
In this context, myocardial revascularization without
the use of cardiopulmonary bypass was investigated and
has demonstrated reduced complications related to cardio-
pulmonary bypass.4,6 Furthermore, there is doubt as to the
effectiveness of the off-pump procedure, which may be
relevant for only certain groups of patients, especially those
at high risk.
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The presence of severe left ventricular dysfunction is an
additional risk factor for CABG, but it has been demon-
strated that even in this group of patients, both revascular-
ization techniques may be safe.7-9
The aim of this study is to assess the safety and efficacy of
myocardial revascularization without cardiopulmonary
bypass in patients with markedly depressed ventricular
function (,20%) by comparing the results with a series of
patients operated upon in the conventional manner.
METHODS AND PATIENTS
Between January 2001 and December 2005, 217 nonran-
domized, consecutive and unselected patients with an
ejection fraction less than 0.20 underwent CABG as an
isolated procedure; 112 who had undergone operations (the
CPB group) and 105 without cardiopulmonary bypass (off-
pump group). The inclusion criteria were all patients with
an echocardiographic ejection fraction below 20% under-
going CABG in one hospital and operated upon by the same
surgical team.
Operating with or without cardiopulmonary bypass was
left to the surgeon’s discretion. The decision was made
during the preoperative evaluation based primarily on the
coronary anatomy (mainly position and diameter of the
target vessel). Decreased vessel diameter and more diffuse
disease were observed in the pump group.
The protocol was approved by the institutional ethics
committee (0369/02).
The demographic data collected are shown in Table 1.
Hospital mortality was defined as death during the same
hospital stay. Stroke was defined as a new focal deficit or a
comatose state lasting more than 24 hours. Acute myocar-
dial infarction was defined as elevated serum CK-
MB.30 IU/L, the presence of new electrocardiographic
changes indicative of necrosis, or new akinetic segments
revealed by echocardiography. Acute renal failure was
defined as a postoperative creatinine level greater than
2.0 mg/dL (with a history of prior normal renal function).
Operative Technique
The decision about whether to perform cardiopulmonary
bypass was a personal decision made by the surgical team.
Once the decision had been made, standard protocols were
followed, including the administration of heparin at a dose
of 4 mg/kg. Cardiopulmonary bypass was established
through a cannula inserted in the ascending aorta and right
atrium, with nonpulsatile blood flow of approximately
2.4 L/min/m2 associated with moderate hypothermia
(28 C˚) and a membrane oxygenator. Myocardial protection
was achieved by anterograde blood perfusion at systemic
temperature, with a hyperkalemic cardioplegia infusion,
repeated during 3 minutes every 15 minutes to maintain an
average pressure above 70 mmHg at the aortic root.
Continuous 7-0 polypropylene monofilament sutures were
placed. Proximal saphenous vein anastomoses were created
in the aorta with a cross clamp during the cardiopulmonary
bypass.
In the patients who underwent revascularization without
cardiopulmonary bypass, compression or suction stabilizers
as well as intracoronary shunts were used at the discretion
of the surgical team. Heparin was administered at a dose of
2 mg/kg. Additional maneuvers were used during cardiac
exposure in order to maintain cardiac output, including the
opening of the right pleural space and the use of a deep
pericardial traction suture. Continuous 7-0 polypropylene
monofilament sutures were placed. The visualization of
target vessels was aided by intermittent instillation of saline
with a syringe. Proximal anastomoses were performed
using a partial occlusion clamp. Site selection was per-
formed by ascending aorta palpation to avoid plaques. No
additional methods, such as an epiaortic scan, were used.
The left internal thoracic artery was used in all cases
(unless it had been used before or presented with
inadequate flow after dissection) for connection to the
anterior descending artery. The remaining targets received
saphenous vein grafts.
Statistical Analysis was performed using the EPI-INFO of
the World Health Organization (WHO), public domain,
version 3.3.2, February 2005. The chi-square test was used
for nominal variables, and the Mann-Whitney U test was
used when appropriate.
RESULTS
The mortality of patients undergoing intervention with
CPB was 12.5% (14/112) versus 3.8% (4/105) in the off-
pump group (p= 0.008). There were no statistically signifi-
cant differences in the following postoperative complica-
tions: acute myocardial infarction — three patients (2.7%) in
the CPB group and four (3.8%) in the off-pump group;
reoperation for graft occlusion — one patient (0.9%) in the
CPB group and one patient (0.95%) in the off-pump group;
and congestive heart failure — nine cases (8%) in the CPB
group and six (5.7%) in the off-pump group. The other
Table 1 - Demographic data in CPB and off-pump groups.
Variable CPB
Off-
pump p-value
n % N %
Number 112 100 105 100
Age (median) 67¡2 71¡3 NS
Sex Female 23 20.5 27 25.7 0.36
Reoperative 11 9.8 18 17.1 0.11
Tobacco Use 29 25.9 26 24.8 0.84
Diabetes 38 33.9 31 29.5 0.48
Chronic Renal Failure 10 8.9 12 11.4 0.54
Hemodialysis 7 6.25 8 7.6 0.69
Body Mass Index . 40 8 7.1 9 8.1 0.69
Emergency Procedure 7 6.25 4 3.8 0.41
Heart Failure
(NYHA.3) admission
12 10.7 23 21.9 0.55
Heart Failure
(NYHA.3) previous
13 11.6 16 15.2 0.43
Previous Myocardial
Infarction
40 35.7 42 40 0.51
Unstable Angina 81 72.3 75 71.4 0.88
Hypertension 59 52.7 70 66.7 0.05
COPD 13 11.6 14 13.3 0.7
Dyslipidemia 48 42.8 40 38 0.47
Atrial Fibrillation 13 11.6 12 11.4 0.96
CVA 8 7.1 4 3.8 0.28
Peripheral Artery
Disease
14 12.5 16 15.2 0.55
Left Ventricle Ejection
Fraction (%)
17¡2 16¡3 0.55
NYHA: New York Heart Association.
COPD: Chronic Obstructive Pulmonary Disease.
CVA: Cerebrovascular Accident.
NS: Nonsignificant.
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variables presented significant differences, as described in
Table 2, with significant reduction of mortality and
morbidity in patients undergoing CABG without cardio-
pulmonary bypass.
There was no incomplete revascularization in any group
and no conversions (cross-over). The descending anterior
artery territory was revascularized in all patients. The
remaining territories (lateral and right) did not reveal any
statistically significant differences between the CPB and off-
pump groups.
DISCUSSION
One of the persistent challenges in coronary disease
treatment is treating patients with ventricular dysfunction.
It is known that the clinical treatment yields poor results
with high mortality.10 CABG in these patients is challen-
ging, with reduced ventricular function directly reflecting
procedure risk and representing an independent risk factor
for morbidity and mortality.11,12 Interestingly, these are the
patients who benefit most from surgical treatment.13
Although operation with CPB is considered the gold
standard, several strategies have been recently used in order
to decrease the complications related to its use and to
improve outcomes.14 The nonuse of cardiopulmonary
bypass has been shown to be safe and effective, even
superior to conventional operations,7,8 even in patients with
left ventricular dysfunction.15
This finding would lead to more complications and
postoperative mortality in patients with ventricular dys-
function who underwent the procedure with cardiopul-
monary bypass. In our study, we observed that the
mortality rate, intubation time, ICU and total stay were
significantly greater in the group with CPB use. The
significantly lower incidence of complications in the off-
pump group applied to postoperative bleeding, transfusion
requirements, reoperation for bleeding, acute renal failure,
hemodialysis, and stroke. This trend was also observed in
the literature.4
Criticisms of the procedure without cardiopulmonary
bypass addressed the incomplete revascularization, possibly
reduced graft patency and long-term results. A common
finding in the literature is a reduced number of grafts in the
procedures performed without cardiopulmonary bypass,
which raises questions about revascularization complete-
ness.
The mortality rate of our sample (12.5% CPB and 3.8% off-
pump) is comparable to findings in other series of patients
with left ventricular dysfunction operated upon with and
without cardiopulmonary bypass. However, most of those
series involved an ejection fraction above the average found
in our series.16-18
Most CABG studies in patients with ventricular dysfunc-
tion include patients with an ejection fraction below 35%,
which promotes averages well above 20%,8,19 representing
the focus of our study. There is a significant hemodynamics
difference between patients with ejection fractions of 20%
and 35%.
Survival studies in patients with severe left ventricular
dysfunction (EF 18%) after coronary artery bypass grafting
in 86 patients demonstrated a mortality rate of 11%, and
those who survived showed improvement of left ventricular
contraction resulting from a significant decrease in left
ventricle diastolic diameter and an increase in left ventri-
cular ejection fraction, with a median survival of 59% at five
years and significant improvement in NYHA functional
class.20 These findings are similar to the data recorded for
the CPB group of this study.
A large retrospective series comparing patients with
ventricular dysfunction who underwent operation with
and without cardiopulmonary bypass failed to show
Table 2 - Postoperative variables.
CPB p-value Off-pump p-value
n % n %
Grafts 2.6 - 2.15 - 0.06-
LIMA-LAD 105 - 100 - 0.62
ICU stay (days) 3.76 - 2.12 - 0.004
Length of Stay (days) 11.3 - 7.2 - 0.001
IABP use 5 4.5 0 0 0.028
Mechanical Ventilation (hours) 22.3 - 10.2 - 0.02
Pneumonia 12 10.7 3 2.8 0.022
Perioperative Myocardial Infarction 3 2.7 4 3.8 0.95
Acute Renal Failure 10 8.9 2 1.9 0.023
Hemodialysis 4 3.6 1 0.95 0.19
Reoperation (graft occlusion) 1 0.9 1 0.95 0.96
AF (postoperative) 13 11.6 10 9.5 0.62
Bleeding (mL) 654 - 440 - 0.022
Packed Red Blood Cells (units) 3 0.8 2 0.2 0.01
Cardiac Failure 9 8 6 5.7 0.90
Pulmonary Edema 9 8 6 5.7 0.9
LVEF (postoperative) (%) 22 - 29 - 0.02
Mortality 14 12.5 4 3.8 0.008
Stroke 3 2.7 1 0.95 0.34
Reoperation – Bleeding 3 2.7 1 0.9 0.205
LIMA-LAD: Left Internal Mammary Artery to Left Anterior Descending Artery.
ICU – Intensive Care Unit.
IABP – Intra-Aortic Balloon Pump.
AF – Atrial Fibrillation.
LVEF – Left-Ventricle Ejection Fraction.
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differences between the two groups, even when paired,
suggesting that the off-pump procedure is safe and possibly
leads to fewer complications in spite of the lack of
statistically significant findings.21
Admitting that a low ejection fraction is synonymous with
a bad ventricle is controversial. There are patients with low
ejection fractions who have good functional capacity for
years and others with comparable ejection fractions that
require high doses of medications and even a heart
transplant.22 Thus, other ways of quantifying the functional
cardiac reserve should be used in order to stratify these
patients more effectively.23 That finding may partly explain
the differences found in several studies.
The finding of lower complication incidence in the group
operated upon without extracorporeal circulation is con-
sistent with the literature, even in patients with markedly
reduced ejection fractions. Factors such as shorter duration
of intubation and fewer pulmonary complications can be
explained by the possibility of cardiopulmonary bypass
inducing pulmonary dysfunction secondary to complement
activation, neutrophil sequestration in pulmonary micro-
circulation and an increase in pulmonary capillary perme-
ability, and interstitial pulmonary edema.24
The incidence of neurological complications in our
sample was low and, although suggested to be lower in
the off-pump group, did not reach statistical significance. A
larger sample size might be able to more clearly document
this difference. However, it is consistent with published
findings (1%–5%) showing that most accidents are related to
embolic events occurring during cannulation, cardiopul-
monary bypass, and aortic surgical manipulation.25,26
The observation of minor renal failure in the CPB group is
also compatible with literature findings demonstrating that
patients undergoing CABG with CPB have a higher risk of
developing acute renal failure because of decreased perfu-
sion, the absence of pulsatile flow, excessive hemolysis,
embolization of platelet aggregates, and fibrin.4
Another interesting finding is the fact that the applic-
ability of the technique is very heterogeneous among
different groups, showing that certain groups achieve
unsatisfactory results with the off-pump technique.27 This
demonstrates that the procedure is often highly dependent
on the skill of the surgical team in performing beating-heart
CABG in technically challenging scenarios, such as the
presence of severe ventricular dysfunction.
A recent meta-analysis demonstrated higher mortality in
patients operated upon without cardiopulmonary bypass,
possibly because of higher graft occlusion and a higher rate
of incomplete revascularization.28 Unfortunately, these
figures were heavily influenced by the Rooby Trial results,
which yielded highly unsatisfactory results and demon-
strated several methodological biases.27
Finally, studies comparing CABG with and without
cardiopulmonary bypass often fail to demonstrate signifi-
cant differences, especially because of the failure to include
patients with multiple risk factors or very low ejection
fractions. Recently, the ongoing CORONARY Trial has
randomized patients with multiple and significant risk
factors for revascularization with and without CPB in order
to determine the possible benefits and disadvantages
associated with both techniques.
Several limitations are inherent to this study design, such
as the fact that there is no randomization. Randomized
studies in patients with severe ventricular dysfunction are
unlikely to be conducted, given the diversity of the technical
limitations of off-pump CABG, especially in circumflex
artery territory in patients with severe dysfunction. Another
bias is the selection procedure, based on the surgeon’s
selection of intraoperative clinical conditions, his or her
personal experience, vessel diameter, the position and
presence of diffuse disease, and whether or not the
procedure was performed using CPB.
A smaller number of grafts in the group without
extracorporeal circulation also contributes to the imbalance
between the groups (despite not being statistically differ-
ent), but the fact that complete revascularization rate and
risk factors are similar contributes to a more adequate
comparison between groups.
This sample follow-up includes only the in-hospital
phase; studies of medium- and long-term effects must be
conducted in order to determine the durability of this initial
advantage in terms of comparative survival, such as
hospital readmission, reintervention, and quality of life.
Currently the long-term results are under review as part of a
separate submission. Another concern is the retrospective
analysis, which lacked randomization. Despite this fact,
similarity between groups could reduce the selection bias.
Few studies have evaluated patients with severe ventri-
cular dysfunction. Our data show that, even in this group,
the morbidity and mortality of the procedure is acceptable
and favors the group operated upon without cardiopul-
monary bypass.
In this context, the use of cardiopulmonary bypass should
be considered in assigning risk scores as well as contribute
to the choice of surgical strategy in patients with ejection
fractions below 20%. Coronary artery bypass surgery today
is safe, efficient and low risk, but poor left-ventricular
function still represents a significant risk factor.
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